Cambridge, MA, United States of America

Mike Smith

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Mike Smith

Introduction

Mike Smith is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of lipid nanoparticles, with a focus on methods that enhance the delivery of therapeutics. With a total of 2 patents, his work is paving the way for advancements in medical technology.

Latest Patents

Mike Smith's latest patents include innovative methods of producing nucleic acid lipid nanoparticle (LNP) compositions. These methods employ a modifying agent after the formation of a precursor nucleic acid lipid nanoparticle. The produced compositions are useful in delivering therapeutics and prophylactics, such as nucleic acids, to mammalian cells or organs. This technology aims to regulate polypeptide, protein, or gene expression, showcasing the potential impact of his inventions on healthcare.

Career Highlights

Mike Smith is currently associated with Modernatx, Inc., where he continues to develop groundbreaking technologies. His expertise in lipid nanoparticles has positioned him as a key player in the field of biotechnology. His contributions are not only advancing scientific knowledge but also enhancing therapeutic applications.

Collaborations

Mike collaborates with talented individuals such as Joseph Schariter and Kimberly Hassett. Their combined efforts contribute to the innovative environment at Modernatx, Inc., fostering creativity and progress in their projects.

Conclusion

In summary, Mike Smith's work in lipid nanoparticles represents a significant advancement in the delivery of therapeutics. His patents and collaborations highlight his commitment to innovation in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…